Inventor
WEBBER STEPHEN E
US46 patents
⚠️ This page may combine multiple inventors who share the name “WEBBER STEPHEN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ANADYS PHARMACEUTICALS INC
12 patentsUS6924271B2Aug 2, 2005
3-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC123 citations97
US7560544B2Jul 14, 2009
3,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
ANADYS PHARMACEUTICALS INC16 citations92
US7709448B2May 4, 2010
Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
ANADYS PHARMACEUTICALS INC13 citations83
US7745415B2Jun 29, 2010
3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC6 citations73
US7462611B2Dec 9, 2008
Pyrro[1,2-b]pyridazinone compounds
ANADYS PHARMACEUTICALS INC5 citations73
US7425552B2Sep 16, 2008
Pyridazinone compounds
ANADYS PHARMACEUTICALS INC7 citations73
US7582754B2Sep 1, 2009
Pyrro[1,2-b]pyridazinone compounds
ANADYS PHARMACEUTICALS INC6 citations72
US7321033B2Jan 22, 2008
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC7 citations72
US7528115B2May 5, 2009
Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines
ANADYS PHARMACEUTICALS INC2 citations62
US7943759B2May 17, 2011
3-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereof
ANADYS PHARMACEUTICALS INC3 citations61
US7842838B2Nov 30, 2010
Pyrro[1,2-b]pyridazinone intermediates
ANADYS PHARMACEUTICALS INC0 citations51
US7781581B2Aug 24, 2010
Process for the preparation of 5-amino-3H-thiazolo[4,5-d]pyrimidin-2-one
ANADYS PHARMACEUTICALS INC0 citations35
AGOURON PHARMA
9 patentsUS5707992AJan 13, 1998
Antiproliferative quinazolines
AGOURON PHARMA44 citations95
US5430148AJul 4, 1995
Antiproliferative quinazolines
AGOURON PHARMA75 citations94
US5962487AOct 5, 1999
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA25 citations91
US5856530AJan 5, 1999
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA32 citations91
US5885996AMar 23, 1999
Antiproliferative quinazolines
AGOURON PHARMA36 citations90
US6362166B1Mar 26, 2002
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA14 citations82
US6214799B1Apr 10, 2001
Antipicornaviral compounds and methods for their use and preparation
AGOURON PHARMA11 citations72
US6953858B2Oct 11, 2005
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA4 citations57
US7179918B2Feb 20, 2007
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA0 citations47
EFFECTOR THERAPEUTICS INC
8 patentsUS9814718B2Nov 14, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC5 citations83
US9669031B2Jun 6, 2017
MNK inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC12 citations83
US9382248B2Jul 5, 2016
Mnk inhibitors and methods related thereto
EFFECTOR THERAPEUTICS INC14 citations83
US11130757B2Sep 28, 2021
Crystalline forms of MNK inhibitors
EFFECTOR THERAPEUTICS INC2 citations70
US10112955B2Oct 30, 2018
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
EFFECTOR THERAPEUTICS INC2 citations70
US10000487B2Jun 19, 2018
Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers
EFFECTOR THERAPEUTICS INC5 citations68
US11952375B2Apr 9, 2024
Crystalline forms of Mnk inhibitors
EFFECTOR THERAPEUTICS INC0 citations60
US11014926B2May 25, 2021
Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2
EFFECTOR THERAPEUTICS INC0 citations51
PRIMMUNE THERAPEUTICS INC
4 patentsUS12187759B2Jan 7, 2025
TLR7 agonists
PRIMMUNE THERAPEUTICS INC0 citations56
US12037335B2Jul 16, 2024
Substituted purines as TLR7 agonists
PRIMMUNE THERAPEUTICS INC0 citations56
US11692005B2Jul 4, 2023
TLR7 agonists
PRIMMUNE THERAPEUTICS INC0 citations56
US11059824B2Jul 13, 2021
Substituted purines as TLR7 agonists
PRIMMUNE THERAPEUTICS INC0 citations56
UNIV TEXAS
3 patentsWEBBER STEPHEN E
3 patentsUS8097718B2Jan 17, 2012
3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
WEBBER STEPHEN E11 citations81
US8883758B2Nov 11, 2014
3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
WEBBER STEPHEN E2 citations59
US8586578B2Nov 19, 2013
Deuterated 5,6-dihydro-1H-pyridin-2-one compounds
WEBBER STEPHEN E0 citations51